163 related articles for article (PubMed ID: 15885836)
21. Improvement of recombinant protein production with the human adenovirus/293S expression system using fed-batch strategies.
Nadeau I; Garnier A; Côté J; Massie B; Chavarie C; Kamen A
Biotechnol Bioeng; 1996 Sep; 51(6):613-23. PubMed ID: 18629828
[TBL] [Abstract][Full Text] [Related]
22. A novel control scheme for inducing angiostatin-human IgG fusion protein production using recombinant CHO cells in a oscillating bioreactor.
Wang IK; Hsieh SY; Chang KM; Wang YC; Chu A; Shaw SY; Ou JJ; Ho L
J Biotechnol; 2006 Feb; 121(3):418-28. PubMed ID: 16162365
[TBL] [Abstract][Full Text] [Related]
23. Hyperosmotic pressure on HEK 293 cells during the growth phase, but not the production phase, improves adenovirus production.
Shen CF; Kamen A
J Biotechnol; 2012 Jan; 157(1):228-36. PubMed ID: 22154564
[TBL] [Abstract][Full Text] [Related]
24. Substitution of glutamine by pyruvate to reduce ammonia formation and growth inhibition of mammalian cells.
Genzel Y; Ritter JB; König S; Alt R; Reichl U
Biotechnol Prog; 2005; 21(1):58-69. PubMed ID: 15903241
[TBL] [Abstract][Full Text] [Related]
25. Wave microcarrier cultivation of MDCK cells for influenza virus production in serum containing and serum-free media.
Genzel Y; Olmer RM; Schäfer B; Reichl U
Vaccine; 2006 Aug; 24(35-36):6074-87. PubMed ID: 16781022
[TBL] [Abstract][Full Text] [Related]
26. Improved fermentation processes for NS0 cell lines expressing human antibodies and glutamine synthetase.
Dempsey J; Ruddock S; Osborne M; Ridley A; Sturt S; Field R
Biotechnol Prog; 2003; 19(1):175-8. PubMed ID: 12573022
[TBL] [Abstract][Full Text] [Related]
27. Suspension culture process of MethA tumor cell for the production of heat-shock protein glycoprotein 96: process optimization in spinner flasks.
Tang YJ; Li HM; Hamel JF
Biotechnol Prog; 2007; 23(6):1363-77. PubMed ID: 17944484
[TBL] [Abstract][Full Text] [Related]
28. Adaptive control at low glucose concentration of HEK-293 cell serum-free cultures.
Siegwart P; Côté J; Male K; Luong JH; Perrier M; Kamen A
Biotechnol Prog; 1999; 15(4):608-16. PubMed ID: 10441351
[TBL] [Abstract][Full Text] [Related]
29. Large-scale propagation of a replication-defective adenovirus vector in stirred-tank bioreactor PER.C6 cell culture under sparging conditions.
Xie L; Metallo C; Warren J; Pilbrough W; Peltier J; Zhong T; Pikus L; Yancy A; Leung J; Auniņs JG; Zhou W
Biotechnol Bioeng; 2003 Jul; 83(1):45-52. PubMed ID: 12740932
[TBL] [Abstract][Full Text] [Related]
30. Retroviral vector production using suspension-adapted 293GPG cells in a 3L acoustic filter-based perfusion bioreactor.
Ghani K; Garnier A; Coelho H; Transfiguracion J; Trudel P; Kamen A
Biotechnol Bioeng; 2006 Nov; 95(4):653-60. PubMed ID: 16947907
[TBL] [Abstract][Full Text] [Related]
31. 293SF metabolic flux analysis during cell growth and infection with an adenoviral vector.
Nadeau I; Jacob D; Perrier M; Kamen A
Biotechnol Prog; 2000; 16(5):872-84. PubMed ID: 11027184
[TBL] [Abstract][Full Text] [Related]
32. Process parameter shifting: Part II. Biphasic cultivation-A tool for enhancing the volumetric productivity of batch processes using Epo-Fc expressing CHO cells.
Trummer E; Fauland K; Seidinger S; Schriebl K; Lattenmayer C; Kunert R; Vorauer-Uhl K; Weik R; Borth N; Katinger H; Müller D
Biotechnol Bioeng; 2006 Aug; 94(6):1045-52. PubMed ID: 16736532
[TBL] [Abstract][Full Text] [Related]
33. Virus-like particle production at low multiplicities of infection with the baculovirus insect cell system.
Maranga L; Brazão TF; Carrondo MJ
Biotechnol Bioeng; 2003 Oct; 84(2):245-53. PubMed ID: 12966582
[TBL] [Abstract][Full Text] [Related]
34. Development of a fed-batch culture process for enhanced production of recombinant human antithrombin by Chinese hamster ovary cells.
Kuwae S; Ohda T; Tamashima H; Miki H; Kobayashi K
J Biosci Bioeng; 2005 Nov; 100(5):502-10. PubMed ID: 16384788
[TBL] [Abstract][Full Text] [Related]
35. Retrovirus producer cell line metabolism: implications on viral productivity.
Coroadinha AS; Alves PM; Santos SS; Cruz PE; Merten OW; Carrondo MJ
Appl Microbiol Biotechnol; 2006 Oct; 72(6):1125-35. PubMed ID: 16598449
[TBL] [Abstract][Full Text] [Related]
36. Serum-free influenza virus production avoiding washing steps and medium exchange in large-scale microcarrier culture.
Genzel Y; Fischer M; Reichl U
Vaccine; 2006 Apr; 24(16):3261-72. PubMed ID: 16472544
[TBL] [Abstract][Full Text] [Related]
37. Derivation and characterization of cholesterol-independent non-GS NS0 cell lines for production of recombinant antibodies.
Hartman TE; Sar N; Genereux K; Barritt DS; He Y; Burky JE; Wesson MC; Tso JY; Tsurushita N; Zhou W; Sauer PW
Biotechnol Bioeng; 2007 Feb; 96(2):294-306. PubMed ID: 16897745
[TBL] [Abstract][Full Text] [Related]
38. Optimization of a feed medium for fed-batch culture of insect cells using a genetic algorithm.
Marteijn RC; Jurrius O; Dhont J; de Gooijer CD; Tramper J; Martens DE
Biotechnol Bioeng; 2003 Feb; 81(3):269-78. PubMed ID: 12474249
[TBL] [Abstract][Full Text] [Related]
39. Human amniocyte-derived cells are a promising cell host for adenoviral vector production under serum-free conditions.
Silva AC; Simão D; Küppers C; Lucas T; Sousa MF; Cruz P; Carrondo MJ; Kochanek S; Alves PM
Biotechnol J; 2015 May; 10(5):760-71. PubMed ID: 25943527
[TBL] [Abstract][Full Text] [Related]
40. Improvement in the suspension-culture production of recombinant adeno-associated virus-LacZ in HEK-293 cells using polyethyleneimine-DNA complexes in combination with hypothermic treatment.
Feng L; Guo M; Zhang S; Chu J; Zhuang Y; Zhang S
Biotechnol Appl Biochem; 2008 Jun; 50(Pt 2):121-32. PubMed ID: 17880281
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
